Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial
Up to 60% of patients with Crohn's disease need intestinal resection within the first 10 years of diagnosis. We investigated whether mercaptopurine can prevent or delay postoperative clinical recurrence.
